De-identification
Unstructured clinical text is scanned for direct identifiers and replaced before release to research. Detection combines named entity recognition, pattern recognizers and an institution-specific medical record number recognizer.
Identifiers found
18
In report 1
Date Time
6
Replaced
Person
5
Replaced
Phone Number
2
Replaced
Medical Record Number
1
Replaced
Original (restricted)
SURGICAL PATHOLOGY REPORT (Diagnostic)
Patient: Patricia GonzalezPerson MRN: RP1002009Medical Record Number DOB: 10/01/1968Date Time
Accession: SP-19-93847Accession Number Collected: 09/29/2019Date Time Received: 09/29/2019Date Time Signed out: 10/01/2019Date Time
Ordering physician: Rebecca ParkerPerson, MD
Specimen: Breast, right, core needle biopsy
FINAL DIAGNOSIS:
Invasive ductal carcinoma, Nottingham grade 2. Estrogen receptor positive, progesterone receptor positive, HER2 1+ by IHC.
CLINICAL HISTORY:
Patricia GonzalezPerson is a 51 year old with an abnormal imaging finding referred for tissue diagnosis.
COMMENT:
Results were discussed with Rebecca ParkerPerson, MD by telephone on 10/01/2019Date Time at (716) 507-8654Phone Number. The patient may be reached at (716) 488-2953Phone Number; address on file 8722 Transit RdStreet Address, BuffaloLocation, NY 14218Zip Code.
Electronically signed by Rebecca NelsonPerson, MD on 10/01/2019Date Time.
De-identified (research release)
SURGICAL PATHOLOGY REPORT (Diagnostic)
Patient: [NAME] MRN: [MRN] DOB: [DATE]
Accession: [ACCESSION] Collected: [DATE] Received: [DATE] Signed out: [DATE]
Ordering physician: [NAME], MD
Specimen: Breast, right, core needle biopsy
FINAL DIAGNOSIS:
Invasive ductal carcinoma, Nottingham grade 2. Estrogen receptor positive, progesterone receptor positive, HER2 1+ by IHC.
CLINICAL HISTORY:
[NAME] is a 51 year old with an abnormal imaging finding referred for tissue diagnosis.
COMMENT:
Results were discussed with [NAME], MD by telephone on [DATE] at [PHONE]. The patient may be reached at [PHONE]; address on file [ADDRESS], [LOCATION], NY [ZIP].
Electronically signed by [NAME], MD on [DATE].
Automated de-identification is one control. Release under the HIPAA Expert Determination method relies on a statistical re-identification risk assessment and determination performed by an independent qualified expert, with periodic reassessment as data sources and uses change.